無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インドのドラッグデリバリー装置市場の将来展望:中央静脈カテーテル、輸液システム、ニードルフリー注射器、定量噴霧吸入器 (MDI)

India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

発行 GlobalData 商品コード 537212
出版日 ページ情報 英文 143 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.36円で換算しております。
Back to Top
インドのドラッグデリバリー装置市場の将来展望:中央静脈カテーテル、輸液システム、ニードルフリー注射器、定量噴霧吸入器 (MDI) India Drug Delivery Devices Market Outlook to 2023 - Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
出版日: 2017年08月01日 ページ情報: 英文 143 Pages
概要

当レポートでは、インドにおける各種のドラッグデリバリー装置 (薬剤送達装置) の市場について分析し、全体的な市場動向の推移や見通し (過去・今後8年間分)、製品カテゴリー別の詳細動向、主要企業・流通チャネルの市場シェア、主なパイプライン製品の現在の治験状況、昨今の資本取引・事業展開の動き、主要企業のプロファイルなどについて調査しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • ドラッグデリバリー装置市場の内訳
  • 当レポートの分析対象市場の定義

第3章 インドのドラッグデリバリー装置市場

  • 市場収益額動向:金額ベース (通算15年間分)
  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額:カテゴリー別シェアの比較 (通算15年間分)
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模動向:数量ベース (通算15年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:企業別

第4章 インドの中央静脈カテーテル市場

  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第5章 インドの輸液システム市場

  • 市場収益額の構造:金額ベース
  • 市場収益額:カテゴリー別シェア
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
    • 携帯型輸液ポンプの市場収益額:実績値・予測値 (通算15年間分)
    • シリンジポンプの市場収益額:実績値・予測値 (通算15年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
    • 携帯型輸液ポンプの市場規模:実績値・予測値 (通算15年間分)
    • シリンジポンプの市場規模:実績値・予測値 (通算15年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第6章 インドのニードルフリー注射器市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第7章 インドの定量噴霧吸入器 (MDI) 市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場規模の実績値:数量ベース (過去8年間分)
  • 市場規模の予測値:数量ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第8章 主要企業のプロファイル:インドのドラッグデリバリー装置市場

  • Teleflex Inc
    • 企業概要
  • GlaxoSmithKline Plc
  • B. Braun Melsungen AG
  • Baxter International Inc
  • AstraZeneca Plc
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Pfizer Inc
  • Smiths Medical
  • Merck & Co Inc
  • Cipla Ltd
  • Hospira Inc
  • テルモ
  • Becton Dickinson and Co
  • Medtronic Plc
  • ニプロ

第9章 ドラッグデリバリー装置市場のパイプライン製品

第10章 資本取引環境

  • 企業買収
  • 資産取引
  • 株式発行
  • 事業提携

第11章 近年の主な動き

  • 企業からの発表 (コーポレート・コミュニケーション)
  • 決算発表
  • 法令・規制関連
  • その他の主な動き
  • 製品ニュース
  • 戦略・事業計画

第12章 付録

図表一覧

目次
Product Code: GDMEMC0250DB

GlobalData's new report, "India Drug Delivery Devices Market Outlook to 2023", provides key market data on the India Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope:

  • Market size and company share data for Drug Delivery Devices market categories - Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market categories.
  • Global corporate-level profiles of key companies operating within the India Drug Delivery Devices market.
  • Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy:

  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Drug Delivery Devices Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Drug Delivery Devices Market, India

  • 3.1. Drug Delivery Devices Market, India, Revenue ($m), 2009-2023
  • 3.2. Drug Delivery Devices Market, India, Revenue Mix ($m), 2016
  • 3.3. Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016
  • 3.4. Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
  • 3.5. Drug Delivery Devices Market, India, Revenue ($m), 2009-2016
  • 3.6. Drug Delivery Devices Market, India, Revenue ($m), 2016-2023
  • 3.7. Drug Delivery Devices Market, India, Volume (Units), 2009-2023
  • 3.8. Drug Delivery Devices Market, India, Volume (Units), 2009-2016
  • 3.9. Drug Delivery Devices Market, India, Volume (Units), 2016-2023
  • 3.10. Drug Delivery Devices Market, India, Company Share by Revenue ($m), 2016

4. Central Venous Catheters Market, India

  • 4.1. Central Venous Catheters Market, India, Revenue Mix ($m), 2016
  • 4.2. Central Venous Catheters Market, India, Segment Contribution (%), 2016
  • 4.3. Central Venous Catheters Market, India, Revenue ($m), 2009-2016
  • 4.4. Central Venous Catheters Market, India, Revenue ($m), 2016-2023
  • 4.5. Central Venous Catheters Market, India, Volume (Units), 2009-2016
  • 4.6. Central Venous Catheters Market, India, Volume (Units), 2016-2023
  • 4.7. Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016
  • 4.8. Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016

5. Infusion Systems Market, India

  • 5.1. Infusion Systems Market, India, Revenue Mix ($m), 2016
  • 5.2. Infusion Systems Market, India, Segment Contribution (%), 2016
  • 5.3. Infusion Systems Market, India, Revenue ($m), 2009-2016
  • 5.4. Infusion Systems Market, India, Revenue ($m), 2016-2023
    • 5.4.1. Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2009-2016
    • 5.4.2. Syringe Pumps Market, India, Revenue ($m), by Segment, 2009-2016
    • 5.4.3. Ambulatory Infusion Pumps Market, India, Revenue ($m), by Segment, 2016-2023
    • 5.4.4. Syringe Pumps Market, India, Revenue ($m), by Segment, 2016-2023
  • 5.5. Infusion Systems Market, India, Volume (Units), 2009-2016
  • 5.6. Infusion Systems Market, India, Volume (Units), 2016-2023
    • 5.6.1. Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2009-2016
    • 5.6.2. Syringe Pumps Market, India, Volume (Units), by Segment, 2009-2016
    • 5.6.3. Ambulatory Infusion Pumps Market, India, Volume (Units), by Segment, 2016-2023
    • 5.6.4. Syringe Pumps Market, India, Volume (Units), by Segment, 2016-2023
  • 5.7. Infusion Systems Market, India, Distribution Share by Revenue ($m), 2015-2016
  • 5.8. Infusion Systems Market, India, Company Share by Revenue ($m), 2016

6. Needle Free Injections Market, India

  • 6.1. Needle Free Injections Market, India, Revenue ($m), 2009-2016
  • 6.2. Needle Free Injections Market, India, Revenue ($m), 2016-2023
  • 6.3. Needle Free Injections Market, India, Volume (Units), 2009-2016
  • 6.4. Needle Free Injections Market, India, Volume (Units), 2016-2023
  • 6.5. Needle Free Injections Market, India, Distribution Share by Revenue ($m), 2015-2016
  • 6.6. Needle Free Injections Market, India, Company Share by Revenue ($m), 2016

7. Metered Dose Inhaler Devices Market, India

  • 7.1. Metered Dose Inhaler Devices Market, India, Revenue ($m), 2009-2016
  • 7.2. Metered Dose Inhaler Devices Market, India, Revenue ($m), 2016-2023
  • 7.3. Metered Dose Inhaler Devices Market, India, Volume (Units), 2009-2016
  • 7.4. Metered Dose Inhaler Devices Market, India, Volume (Units), 2016-2023
  • 7.5. Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), 2015-2016
  • 7.6. Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), 2016

8. Overview of Key Companies in India, Drug Delivery Devices Market

  • 8.1. Teleflex Inc
    • 8.1.1. Company Overview
  • 8.2. GlaxoSmithKline Plc
    • 8.2.1. Company Overview
  • 8.3. B. Braun Melsungen AG
    • 8.3.1. Company Overview
  • 8.4. Baxter International Inc
    • 8.4.1. Company Overview
  • 8.5. AstraZeneca Plc
    • 8.5.1. Company Overview
  • 8.6. Boehringer Ingelheim GmbH
    • 8.6.1. Company Overview
  • 8.7. Fresenius Kabi AG
    • 8.7.1. Company Overview
  • 8.8. Pfizer Inc
    • 8.8.1. Company Overview
  • 8.9. Smiths Medical
    • 8.9.1. Company Overview
  • 8.10. Merck & Co Inc
    • 8.10.1. Company Overview
  • 8.11. Cipla Ltd
    • 8.11.1. Company Overview
  • 8.12. Hospira Inc
    • 8.12.1. Company Overview
  • 8.12. Terumo Corp
    • 8.12.1. Company Overview
  • 8.19. Becton Dickinson and Co
    • 8.19.1. Company Overview
  • 8.13. Medtronic Plc
    • 8.13.1. Company Overview
  • 8.14. Nipro Corp
    • 8.14.1. Company Overview

9. Drug Delivery Devices Market Pipeline Products

10. Financial Deals Landscape

  • 10.1. Acquisition
    • 10.1.1. Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs
  • 10.2. Asset Transactions
    • 10.2.1. Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter
    • 10.2.2. ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • 10.3. Equity Offerings
    • 10.3.1. Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities
  • 10.4. Partnerships
    • 10.4.1. Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma
    • 10.4.2. PharmaJet Enters into Agreement with Serum Institute of India
    • 10.4.3. Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
    • 10.4.4. Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
    • 10.4.5. Eris Lifesciences Enters into Distribution Agreement with India Medtronic
    • 10.4.6. Pfizer Terminates its Licensing Agreement with pSivida
    • 10.4.7. Bayer Enters into Licensing Agreement with DelSiTech
    • 10.4.8. BioCorRx Enters into Licensing Agreement with Therakine

11. Recent Developments

  • 11.1. Corporate Communications
    • 11.1.1. Jul 12, 2017: Sun Pharmaceutical Industries Announces Appointment of Mr. Kalyansundaram Subramanian as the Director
    • 11.1.2. Jun 09, 2017: Poly Medicure announces appointment of Chief Operating Officer
    • 11.1.3. Apr 12, 2017: Sanofi appoints Nikhilesh Kalra to lead Consumer Healthcare business for India and South Asia
    • 11.1.4. Mar 20, 2017: Piramal Pharma Solutions Names Stuart E. Needleman as Chief Commercial Officer
    • 11.1.5. Feb 08, 2017: Cipla Updates Appoints Mr. Mital Sanghvi To Senior Business Finance Role
    • 11.1.6. Jan 09, 2017: Cipla appoints Peter Lankau as an Independent Director on its Board
    • 11.1.7. Nov 29, 2016: Cipla appoints Ireena Vittal as an Independent Director on its Board
    • 11.1.8. Nov 10, 2016: Morepen Labs: Appoints Additional Director
    • 11.1.9. Aug 12, 2016: Cipla Names Umang Vohra as MD & Global CEO; Samina Vaziralliis Executive Vice-Chairman
    • 11.1.10. Aug 01, 2016: Cipla appoints Kedar Upadhye as Global Chief Financial Officer
  • 11.2. Financial Announcements
    • 11.2.1. May 26, 2017: Sun Pharma reports Q4 & FY17 results
    • 11.2.2. May 25, 2017: Cipla announces Q4 & FY 17 results Continued strong performance across key markets
    • 11.2.3. May 12, 2017: Dr. Reddy's Q4 and FY17 Financial Results
    • 11.2.4. Feb 14, 2017: Sun Pharma reports Q3FY17 results
    • 11.2.5. Feb 08, 2017: Morepen labs reports yet another growth-filled quarter
    • 11.2.6. Feb 04, 2017: Dr. Reddy's Q3 and 9M FY17 Financial Results
    • 11.2.7. Nov 15, 2016: Oncocyte Announces Publication Of Breast Cancer Diagnostic Test Abstract; Poster To Be Presented At The San Antonio Breast Cancer Symposium On December 9, 2016
    • 11.2.8. Nov 14, 2016: Medtronic Receives FDA Approval for Claria MRI Quad Cardiac Resynchronization Therapy Defibrillator
    • 11.2.9. Nov 14, 2016: With Health Canada approval, Dexcom G5 Mobile CGM System is the First and Only Medical Device in North America for Making Daily Diabetes Decisions Without Painful Fingersticks
    • 11.2.10. Nov 11, 2016: CHMP Adopts Positive Opinion to include Self-Administration for RUCONEST
    • 11.2.11. Nov 09, 2016: Cipla announces Q2 FY17 results - Improved profitability in base business & Strengthened R&D pipeline
    • 11.2.12. Nov 09, 2016: Morepen Labs reports 118 pct jump in net profits for the Q2 of FY 2016-17
    • 11.2.13. Oct 25, 2016: Dr. Reddy's Q2 and H1 FY17 Financial Results
    • 11.2.14. Aug 12, 2016: Sun Pharma reports Q1FY17 results
    • 11.2.15. Aug 12, 2016: Sun Pharmaceutical Industries announces Unaudited results for the Quarter ended 30 th June, 2016
    • 11.2.16. Aug 12, 2016: Cipla announces Q1 FY 17 Results Performance reflects continued momentum in key markets and improvement in base EBITDA margins
    • 11.2.17. Aug 01, 2016: Piramal Enterprises Consolidated Results for the First Quarter ended 30 June 2016
    • 11.2.18. Jul 26, 2016: Dr. Reddy's Q1 FY17 Financial Results
  • 11.3. Legal And Regulatory
    • 11.3.1. Jun 16, 2017: Dr. Reddy's Laboratories: Update on USFDA Audit
    • 11.3.2. Jun 14, 2017: Dr. Reddy's Provides Update on API manufacturing plant at Miryalaguda
    • 11.3.3. Jun 01, 2017: Successful AAALAC accreditation for Envigo facilities in Hyderabad, India
    • 11.3.4. May 29, 2017: Phosphagenic - Mylan Arbitration Update - expert report on quantum of damages claimed filed
    • 11.3.5. May 25, 2017: Dr. Reddy's Laboratories Provides Update on Srikakulum Plant
    • 11.3.6. Apr 14, 2017: Dr. Reddy's Provides Update on USFDA Audit
    • 11.3.7. Apr 03, 2017: Dr. Reddy's Laboratories Provides Update on USFDA Inspection at Srikakulam plant
    • 11.3.8. Mar 14, 2017: Sun Pharma Provides Update on Mohali Facility
    • 11.3.9. Mar 14, 2017: Sun Pharmaceutical Industries Provides Update on Mohali Facility
    • 11.3.10. Feb 21, 2017: Dr. Reddy's Laboratories Announces US FDA Inspection on Miryalaguda Facility
    • 11.3.11. Dec 13, 2016: TUV Certification for the Bengaluru Facility
    • 11.3.12. Dec 08, 2016: Sun Pharma Provide Update on USFDA Inspection for Halol facility
    • 11.3.13. Sep 30, 2016: Clarification sought from Cipla
  • 11.4. Other Significant Developments
    • 11.4.1. Feb 08, 2017: Dr. Reddy's Expands Commercial Operations in Europe
    • 11.4.2. Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System
  • 11.5. Product News
    • 11.5.1. May 22, 2017: Aptar Pharma to Highlight Drug Delivery Systems Portfolio at FCE Brazil
  • 11.6. Strategy And Business Planning
    • 11.6.1. Dec 01, 2016: Aptar Pharma Nears Completion Of Elastomer Component Capacity In North America
    • 11.6.2. Oct 07, 2016: Leading global pharmaceutical company, Dr. Reddy's Laboratories now in Colombia
    • 11.6.3. Sep 28, 2016: Piramal plans to expand its API development & manufacturing capabilities at Digwal plant

12. Appendix

  • 12.1. Research Methodology
    • 12.1.1. Coverage
    • 12.1.2. Secondary Research
    • 12.1.3. Primary Research
    • 12.1.4. Company Share Analysis
    • 12.1.5. Distribution Share Analysis
    • 12.1.6. Benchmarking
  • 12.2. GlobalData Consulting
  • 12.3. Contact Us
  • 12.4. Disclaimer

List of Tables

  • Table 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023
  • Table 2: Drug Delivery Devices Market, India, Category Contribution by Revenue ($m), 2016
  • Table 3: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
  • Table 4: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 6: Drug Delivery Devices Market, India, Volume (Units), 2009-2023
  • Table 7: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016
  • Table 8: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023
  • Table 9: Drug Delivery Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 10: Central Venous Catheters Market, India, Segment Contribution (%), 2016
  • Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
  • Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
  • Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 17: Infusion Systems Market, India, Segment Contribution (%), 2016
  • Table 18: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 19: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 20: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 21: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 24: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016
  • Table 25: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023
  • Table 26: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016
  • Table 27: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016
  • Table 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023
  • Table 29: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023
  • Table 30: Infusion Systems Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 31: Infusion Systems Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 32: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 34: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016
  • Table 35: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023
  • Table 36: Needle Free Injections Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 37: Needle Free Injections Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Table 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Table 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016
  • Table 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023
  • Table 42: Metered Dose Inhaler Devices Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016
  • Table 43: Metered Dose Inhaler Devices Market, India, Company Share by Revenue ($m), USD Constant, 2016
  • Table 44: Drug Delivery Devices Market Pipeline Products
  • Table 45: Pinfold Overseas Acquires Additional 6.4% Stake in Morepen Labs
  • Table 46: Eurolife Healthcare Acquires Form-Fill-Seal Infusion Business from Baxter
  • Table 47: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer
  • Table 48: Piramal Enterprises Plans to Raise Up to USD774.6 Million in Issue of Securities
  • Table 49: Sayre Therapeutics Enters into Licensing Agreement with Navidea Biopharma
  • Table 50: PharmaJet Enters into Agreement with Serum Institute of India
  • Table 51: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs
  • Table 52: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma
  • Table 53: Eris Lifesciences Enters into Distribution Agreement with India Medtronic
  • Table 54: Pfizer Terminates its Licensing Agreement with pSivida
  • Table 55: Bayer Enters into Licensing Agreement with DelSiTech
  • Table 56: BioCorRx Enters into Licensing Agreement with Therakine

List of Figures

  • Figure 1: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, 2009-2023
  • Figure 2: Drug Delivery Devices Market, India, Revenue Mix ($m), 2016
  • Figure 3: Drug Delivery Devices Market, India, Category Contribution (%), 2016
  • Figure 4: Drug Delivery Devices Market, India, Category Comparison by Revenue ($m), 2009-2023
  • Figure 5: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 6: Drug Delivery Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 7: Drug Delivery Devices Market, India, Volume (Units), 2009-2023
  • Figure 8: Drug Delivery Devices Market, India, Volume (Units), Historic, 2009-2016
  • Figure 9: Drug Delivery Devices Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 10: Drug Delivery Devices Market, India, Company Share (%) 2016
  • Figure 11: Central Venous Catheters Market, India, Revenue Mix ($m), 2016
  • Figure 12: Central Venous Catheters Market, India, Segment Contribution (%), 2016
  • Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016
  • Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016
  • Figure 18: Infusion Systems Market, India, Revenue Mix ($m), 2016
  • Figure 19: Infusion Systems Market, India, Segment Contribution (%), 2016
  • Figure 20: Infusion Systems Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 21: Infusion Systems Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 22: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 23: Syringe Pumps Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 24: Ambulatory Infusion Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 25: Syringe Pumps Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 26: Infusion Systems Market, India, Volume (Units), Historic, 2009-2016
  • Figure 27: Infusion Systems Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 28: Ambulatory Infusion Pumps Market, India, Volume (Units), Historic, 2009-2016
  • Figure 29: Syringe Pumps Market, India, Volume (Units), Historic, 2009-2016
  • Figure 30: Ambulatory Infusion Pumps Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 31: Syringe Pumps Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 32: Infusion Systems Market, India, Company Share (%) 2016
  • Figure 33: Needle Free Injections Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 34: Needle Free Injections Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 35: Needle Free Injections Market, India, Volume (Units), Historic, 2009-2016
  • Figure 36: Needle Free Injections Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 37: Needle Free Injections Market, India, Company Share (%) 2016
  • Figure 38: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Historic, 2009-2016
  • Figure 39: Metered Dose Inhaler Devices Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023
  • Figure 40: Metered Dose Inhaler Devices Market, India, Volume (Units), Historic, 2009-2016
  • Figure 41: Metered Dose Inhaler Devices Market, India, Volume (Units), Forecast, 2016-2023
  • Figure 42: Metered Dose Inhaler Devices Market, India, Company Share (%) 2016
Back to Top